Stock Events

LigaChem Biosciences 

₩83,200
2
-₩800-0.95% Friday 06:30

Statistics

Day High
84,300
Day Low
79,400
52W High
99,500
52W Low
32,400
Volume
734,390
Avg. Volume
901,647
Mkt Cap
3.11T
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q3 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
-134.74
-134.41
-134.07
-133.74
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 141080.KQ. It's not an investment recommendation.
Alphabet
72554
GOOGL
Apple
63389
AAPL
Microsoft
59081
MSFT
Amazon
54705
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Astellas Pharma
ALPMY
Mkt Cap22.44B
Astellas Pharma US, a subsidiary of Astellas Pharma Inc., competes in the therapeutic areas including oncology, similar to LegoChem Biosciences' market.
I-Mab
IMAB
Mkt Cap87.66M
I-Mab is a biopharma company focused on developing biologics in the field of immuno-oncology and autoimmune diseases, competing in the same biotechnological advancements as LegoChem Biosciences.
BeiGene
BGNE
Mkt Cap21.34B
BeiGene, Ltd. operates in the global biopharmaceutical market, focusing on innovative molecularly targeted and immuno-oncology drug candidates, similar to LegoChem Biosciences.
Zai Lab Limited
ZLAB
Mkt Cap1.99B
Zai Lab Limited, a biopharmaceutical company, focuses on bringing transformative medicines for cancer, which competes with LegoChem Biosciences' cancer therapy developments.
Xencor
XNCR
Mkt Cap1.08B
Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer, autoimmune diseases, asthma, and allergic diseases, competing in similar fields as LegoChem Biosciences.
SELLAS Life Sciences
SLS
Mkt Cap82.99M
SELLAS Life Sciences Group, Inc. focuses on novel cancer immunotherapies, directly competing with LegoChem Biosciences in the innovative cancer treatment sector.
Adaptimmune Therapeutics
ADAP
Mkt Cap324.8M
Adaptimmune Therapeutics plc specializes in T-cell therapy to treat cancer, competing in the advanced therapy medicinal products sector like LegoChem Biosciences.

About

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Show more...
CEO
Mr. Yong Zu Kim
Country
KR
ISIN
KR7141080002

Listings

KQ
KR
141080.KQ